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ABSTRACT
Photochemotherapy—in which a photosensitizing
drug is combined with ultraviolet or visible radi-
ation—has proven therapeutic effectiveness. Existing
approaches have drawbacks, however, and there is
a clinical need to develop alternatives offering
improved target cell selectivity. DNA substitution
by 4-thiothymidine (S
4TdR) sensitizes cells to killing
by ultraviolet A (UVA) radiation. Here, we demon-
strate that UVA photoactivation of DNA S
4TdR
does not generate reactive oxygen or cause direct
DNA breakage and is only minimally mutagenic. In
an organotypic human skin model, UVA penetration
is sufficiently robust to kill S
4TdR-photosensitized
epidermal cells. We have investigated the DNA
lesions responsible for toxicity. Although thymidine
is the predominant UVA photoproduct of S
4TdR in
dilute solution, more complex lesions are formed
when S
4TdR-containing oligonucleotides are irradi-
ated. One of these, a thietane/S
5-(6-4)T:T, is struc-
turally related to the (6-4) pyrimidine:pyrimidone
[(6-4) Py:Py] photoproducts induced by UVB/C radi-
ation. These lesions are detectable in DNA from
S
4TdR/UVA-treated cells and are excised from
DNA more efficiently by keratinocytes than by leu-
kaemia cells. UVA irradiation also induces DNA
interstrand crosslinking of S
4TdR-containing
duplex oligonucleotides. Cells defective in repairing
(6-4) Py:Py DNA adducts or processing DNA
crosslinks are extremely sensitive to S
4TdR/UVA
indicating that these lesions contribute significantly
to S
4TdR/UVA cytotoxicity.
INTRODUCTION
Photochemotherapy combines ultraviolet or visible radi-
ation with photosensitizing drugs to produce cytotoxic
effects which neither drug nor radiation can achieve alone.
Psoralen plus UVA (320–400nm) radiation (PUVA), for
the treatment of cutaneous T-cell lymphoma and psoria-
sis, and photodynamic therapy (PDT) in which tetra-
pyrroles are activated by light to treat external and
internal malignancies (1–3) are established photochemo-
therapies. Although they are highly effective, these
approaches have drawbacks. Long-term use of PUVA is
associated with an increased risk of skin cancer (4,5). PDT
is not completely selective for the tumour tissue and can be
very painful. Hence, further research into alternative
approaches, preferably involving lower radiation doses
and/or improved selectivity is warranted.
The deliberate induction of DNA damage underlies
many successful therapeutic strategies. The canonical
DNA bases are damaged when they absorb ultraviolet
radiation (UVR) in the UVC and UVB spectral regions
(100–320nm), but have no signiﬁcant absorption at UVA
wavelengths (320–400nm). Thus, DNA is largely insensi-
tive to direct UVA-induced photochemical damage and
skin is about 1000 times less sensitive to UVA than to
UVB both at the molecular and clinical levels (6). The
thiopurine 6-thioguanine (6-TG) and the thiopyrimidine
4-thiothymine (S
4T) are examples of base analogs that
are UVA chromophores with absorbance maxima being
 340nm. Both are incorporated efﬁciently into DNA of
dividing cells where they exhibit a profound synergistic
cytotoxicity with UVA radiation (7–9).
4-Thiothymidine (S
4TdR) is metabolized via the thymi-
dine kinase (TK)-mediated pyrimidine nucleoside salvage
pathway (8). TK is strongly up-regulated during DNA
replication (10) and is more active in rapidly dividing
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advantage, as exempliﬁed by triﬂuorothymidine [recently
reviewed (12)]. Unlike triﬂuorothymidine, S
4TdR itself is
not detectably toxic or mutagenic in cultured human cells
(8). In combination with low dose UVA, however, it
causes signiﬁcant toxicity in rapidly dividing cells and
UVA sensitization factors of  100-fold are easily achiev-
able (8,9). This effect is largely independent of p53 status
(9). These two properties: selective sensitization of rapidly
dividing cells and p53 independence are key properties for
a treatment aimed at cancers in which p53 is often
mutated or absent.
The mechanism by which DNA S
4TdR increases cellular
UVA sensitivity is yet to be elucidated. The UVA energy
absorbed by thiobases in DNA can cause DNA damage
by Type I photosensitization, or it may be transferred
to molecular oxygen to generate reactive oxygen species
(ROS) in a Type II photosensitization reaction. ROS
cause damage to DNA and proteins, and Type II photo-
sensitization is the predominant mechanism by which the
DNA thiopurine 6-TG exerts its photochemical effects
(7,13,14).
Nucleotide excision repair (NER)-defective xeroderma
pigmentosum (XP) cells are particularly sensitive to the
combination of S
4TdR and UVA (8). This indicates that
the treatment produces potentially lethal DNA lesions that
are normally removed by NER. This DNA repair pathway
efﬁciently removes the (6-4) pyrimidine:pyrimidone [(6-4)
Py:Py] intrastrand DNA crosslinks induced by UVC and
UVB radiation. A thietane photoproduct that is formed in
a UVA-activated reaction between S
4T with an adjacent
thymine, and which resembles a (6-4) Py:Py DNA photo-
product, is a candidate for this potentially lethal NER
substrate (15,16).
In the study reported here, UVA penetration of in vitro
reconstituted skin is shown to be sufﬁciently robust to
selectively kill dividing epidermal cells that contain
DNA S
4TdR. We demonstrate that DNA S
4TdR photo-
activation involves a predominantly Type I photosen-
sitization and does not generate signiﬁcant levels of
ROS. The combination of S
4TdR and UVA is only
weakly mutagenic in mammalian cultured cells. DNA
S
4TdR photoproducts are identiﬁed and include a DNA
thietane that is repaired by NER.
MATERIALS AND METHODS
Cell culture
Human HaCaT, XP12RO and MRC5VA and all Chinese
hamster cell lines were grown in DMEM containing 10%
fetal calf serum. The human T lymphoblast cell line
CCRF-CEM from acute lymphoblastic leukaemia was
grown in RPMI+10% fetal calf serum. CHO irs1 (xrcc2
mutant) and irs1/XRCC2 (xrcc2 complemented irs1) cells
(17) were provided by Dr John Thacker and CHO XRS6
(Ku80 mutant) and its Ku80
+ parent K1 by Dr Mark
O’Driscoll. The ERCC4(XPF) mutant CHO cell line
UV41, ERCC5(XPG) mutant UV135 and their parental
counterpart AA8 have been described (18,19).
Organotypic skin cultures on de-epidermalized dermis
Organotypic skin cultures were prepared as described (20).
Brieﬂy, glycerol-preserved g-irradiated skin (Euro Skin
Bank, Beverwijk, Holland) was washed extensively in
PBS and incubated in antibiotic-containing PBS at 37 C
for  10 days. The epidermis was then removed using for-
ceps, and de-epidermalized dermis (DED) was cut into
small squares and placed in culture dishes with the papil-
lary dermal surface on the underside. Steel rings were
placed on top of the dermis and normal human dermal
ﬁbroblasts were added into the rings on the reticular
dermal surface. After incubation overnight, the de-
epidermalized dermis was inverted, the rings were replaced
and normal human keratinocytes were seeded inside the
rings onto the dermis. After 2 days, the dermis was raised
to the air–liquid interface in the same orientation, by
placing the composites on steel grids for 14 days. The
medium was replaced every 3 days. At Days 6 and 7,
medium supplemented with S
4TdR was added for 3 days
and the rafts were irradiated. After 24h, they were ﬁxed in
10% formalin and embedded in parafﬁn. Deparafﬁnized
sections were stained with Haematoxylin and Eosin for
histologic examination.
Drug treatment
S
4TdR prepared according to Xu et al. (21) was obtained
from Glen Research (Sterling, VA, USA). It was dissolved
in deionized water, ﬁlter-sterilized and stored at  20 C.
All S
4TdR treatments were for 48h in medium containing
10% FCS which had been dialysed extensively (DFCS)
through a 2kDa exclusion membrane Spectra/Por
(Spectrum Laboratories; Medicell International, Ltd.). In
the mutagenicity assay, N-methly-N-nitrosourea (MNU)
(Sigma Aldrich, UK) was dissolved in dimethylsulphoxide
(DMSO) and added to the medium.
Irradiation
UVA irradiation of oligonucleotides was at 100W/m
2
with a UVH 250W iron bulb with a low range cut-off at
320nm (UVLight Technologies, Birmingham, UK). For
irradiation of cells, the UVA source was a UVASPOT
lamp (Dr. Ho ¨ nle AG UV Technology, Gra ¨ felﬁng/
Mu ¨ nchen, Germany), emitting broadband UVA and
ﬁltered to remove UVB radiation (99.9%). The remaining
0.1% of transmitted UVB represents 10% of erythemally
effective energy (EEE), which at the low UVA doses used
in this study, would not contribute to any biologically
signiﬁcant DNA damage. Cells were irradiated in a thin
layer of PBS containing Ca
2+ and Mg
2+ (PBS/CaMg) at
an irradiance of 16.6W/m
2 and maintained on a
water-cooled plate during irradiation. The UVB irradi-
ation source was a Westinghouse FS20 SunLamp with
peak emission at 313nm. A germicidal lamp equipped
with a G15T8 bulb (Sankyo Denki, Japan) was the
UVC source.
Spectrally relevant UV dosimeters were from
International Light Technologies Inc. (Peabody, MA,
USA) calibrated against spectroradiometric measurements
of the sources made by a DM150 double monochromator
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Ionizing radiation (3.0Gy/min) was from a
137Cs
g-radiation source with a Nordion GC-1000S v2.09 cell
irradiator (Ottawa, ON, Canada).
Cell survival
Irradiated cells were seeded in 48-well plates (5000 cells/
well). Viability was determined 5 days later by MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide) assay. For clonal survival, cells were plated in
6-well plates (300–500 cells/well). Colonies were stained
and counted 10 days later. Data are based on triplicate
samples from at least two experiments.
Detection of ROS
Cells were grown in the presence or absence of S
4TdR for
48h, washed twice with PBS and incubated with 5mM
CM-H2DCFDA (Invitrogen, Paisley, Scotland) for
20min at 37 C. After additional washing with PBS, cells
were UVA irradiated in PBS/CaMg. Fluorescence was
analysed by ﬂow cytometry on a Beckton Dickinson
(BD) Canto II machine.
APRT mutation assay
Mutation Frequency. The Adenine phosphoribosyl-
transferase (APRT) Mutation frequency was determined
using CHO-D422 (22,23). Cells were maintained in HAT
medium to eliminate spontaneous mutants. They were
then grown for 48h in a medium supplemented with
10% DFCS and 100mMS
4TdR and irradiated. After a
further 7 days growth, 10
6 cells were plated per 10cm
dish in medium containing 0.4mM 8-azaadenine. The
number of resistant colonies was determined after a
further 10 days’ growth. At least 1.5 10
7 cells were
plated per experiment.
Immunoﬂuorescence
HaCaT cells grown on culture slides (BD Falcon,
San Jose, CA) in 100mMS
4TdR were irradiated with
10kJ/m
2 UVA. Control cells were irradiated with 10Gy
g-rays. Irradiated cells were rinsed with PBS and returned
to normal medium for 4h. They were then ﬁxed and pro-
cessed for detection of phosphorylated gH2AX as
described by Brem et al. (24). For the detection of CPD
and(6-4) photoproducts, irradiated HaCaT cells were ﬁxed
immediately after UV irradiation. Photoproducts were
detected using antibodies speciﬁc for thymine dimers
(clone TDM-2) or (6-4) Py:Py photoproducts (clone
64M-2) from CosmoBio Co., Ltd (Tokyo, Japan) accord-
ing to the company’s recommendations.
Comet assay
Alkaline comet assays were performed using the Single Cell
Gel Electrophoresis Assay kit (Trevigen, Gaithersburg,
MD, USA) according to the manufacturer’s protocol.
Modiﬁcations with the DNA lesion-speciﬁc enzymes T4
endoV (T4N5) or recombinant human 8-oxoguanine
glycosylase 1 (hOGG-1, both from New England
Biolabs, Hitchin, UK) were performed as described by
Cooke et al. (25). Brieﬂy, after cell lysis, washed slides
were immersed in enzyme digestion buffer (40mM
HEPES, 0.1M KCl, 0.5mM EDTA and 0.2mg/ml BSA,
pH 8.0), for 5min. T4N5 (0.1 U/ml) or hOGG1 (3.2 U/ml)
was added to the gels which were covered with a coverslip
and incubated for 60min (T4N5) or 45min (hOGG1) at
37 C in a humidiﬁed atmosphere. Electrophoresis was
carried out according to the manufacturer’s protocol.
HPLC analysis
S
4TdR. Reverse phase-high performance liquid chroma-
tography (RP-HPLC) analysis of the irradiated nucleoside
was performed using a Waters 2695 Alliance system with a
Waters dC18 column (Atlantis, 3um, 150 2.1mm). The
column was eluted with a gradient of 0–20% methanol in
10mM KH2PO4, pH 6.7 during the ﬁrst 10min. The
methanol concentration was increased to 80% during
the subsequent 10min and to 90% in the following
3min during which the KH2PO4 concentration was
reduced to zero.
DNA. DNA was extracted using the Wizard Genomic
DNA puriﬁcation kit (Promega, Madison, WI, USA).
DNA (50mg) was digested with nuclease P1 (Sigma
Aldrich, UK) (10 U, 1h at 50 C) and alkaline phosphatase
(2 U, 1h at 37 C). Deoxyribonucleosides were separated
by HPLC (7). Thymidine was detected and quantiﬁed by
A260nm and S
4TdR by A335.
Interstrand crosslink detection
The oligonucleotides complementary to S
4TdR oligo-
nucleotides were [
32P] end-labelled with polynucleotide
kinase. Following annealing to their complementary
strand, duplex oligonucleotides were UVA irradiated,
heat-denatured and analysed by denaturing PAGE
followed by autoradiography (26).
RESULTS
S
4TdR/UVA-induced cytotoxicity in an organotypic
skin model
The powerful synergistic toxicity of S
4TdR and UVA was
tested in an organotypic 3D skin model. Reconstituted
skin (raft) cultures comprising human normal primary
ﬁbroblasts and keratinocytes were treated with S
4TdR
by maintaining the rafts in growth medium containing
the photosensitizer. The rafts were then exposed to UVA
doses of  100kJ/m
2 (this is approximately one-ﬁfth of a
minimal erythema dose for human skin) (27) and parafﬁn
sections were examined for the presence of apoptotic ‘sun-
burn’ cells (SBC). Figure 1 shows that the rafts that had
received either UVA (Figure 1B) or S
4TdR (Figure 1C)
alone contained only apparently healthy cells and there
was no sign of apoptosis. SBC were present only in rafts
treated with the combination of drug and radiation
(Figure 1D) and characteristic markers such as pyknosis
(chromatin condensation, leading to enhanced nuclear
colouration) and karyolysis (chromatin degradation
leading to fading of nucleus colouration) were clearly
9622 Nucleic Acids Research, 2011,Vol.39, No. 22visible in the proliferating layers down to the basement
membrane at the epidermal–dermal junction. Notably,
there was no sign of cell damage in the upper
non-proliferating layers of the epidermis. These data dem-
onstrate that sufﬁcient UVA penetrates through to the
proliferating target cell population to activate DNA
S
4TdR and that S
4TdR-containing cells in the epidermis
are susceptible to killing by relatively low doses of UVA.
Mutagenicity
Although the toxicity of the S
4TdR/UVA combination is
well established (8,9), its potential mutagenicity has not
been investigated in detail. We examined mutation to
8-azaadenine-resistance in the APRT hemizygous
Chinese hamster ovary (CHO-D422) cell line. D442 cells
incorporate S
4TdR extremely efﬁciently (Supplementary
Figure S1A) and therefore, provide a sensitive indicator of
S
4TdR/UVA mutagenicity. Cells were exposed to S
4TdR
and UVA alone or in combination and mutant colonies
were scored after 10–12 days. Figure 2 shows that the
most extreme condition (100mMS
4TdR plus 1kJ/m
2
UVA), which reduced cell survival to  1%
(Supplementary Figure S1B) induced a modest 2.4-fold
increase in mutation frequency. Less toxic combinations
increased the mutation frequency by  2-fold. Neither
S
4TdR, nor UVA alone was measurably mutagenic at
these doses. In contrast, in the absence of S
4TdR treat-
ment, a UVA dose of 500kJ/m
2 induced a similar 2- to
4-fold increase in mutation frequency. This value is com-
parable with published results with the same cell line (28)
or other CHO clones (29). Methylnitrosourea, an
A.  Untreated
C.  UVA D.  S4TdR+UVA
B.  S4TdR
Figure 1. Synergistic cytotoxicity of S
4TdR/UVA in organotypic skin cultures.Organotypic skin cultures were treated as indicated and ﬁxed 24h
post-irradiation. Haematoxylin/eosin-stained sections are represented. (A) Untreated. (B) 300mMS
4TdR. (C) 100kJ/m
2 UVA. The skin/cell archi-
tecture is unaffected by treatments in B and C. (D)S
4TdR/UVA combination: Apoptotic (‘sunburn’) keratinocytes displaying pyknosis (enhanced
nuclear colouration) and cells showing karyolysis (loss of nuclear colouration) are shown as arrows. Note the absence of cellular damage in the
upper, non-proliferating layers of the epidermis.
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Figure 2. Mutagenicity of S
4TdR/UVA. CHO-D422 cells grown for
48h in S
4TdR as shown were washed and irradiated with UVA.
Mutation to 8-azaadenine resistance was determined. Data are the
mean of at least three independent determinations±standard devi-
ation. The mean mutation frequency in untreated cells was 2.3 10
 5
(range: 1.2 to 3.8 10
 5). Control cells received either 500kJ/m
2 UVA
alone, 100mMS
4TdR alone or 0.5mM MNU.
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trol, induced a 25-fold increase in mutation frequency.
We conclude that, the mutagenic effect of S
4TdR/UVA
is weak and is similar to that of high-dose UVA.
ROS
High UVA doses generate intracellular ROS. In addition,
the thiopurines are Type II UVA photosensitizers and
DNA 6-TG is a potent source of ROS following UVA
activation (7). To investigate whether photoactivation of
DNA thiopyrimidines might also produce ROS, human
HaCaT keratinocytes were treated with S
4TdR for 48h
to replace  0.1% of DNA thymidine. They were then
irradiated with a range of UVA doses and ROS produc-
tion was measured using the ROS-activated ﬂuorescent
probe CM-H2DCFDA. Flow cytometry analysis
(summarized in Figure 3A) conﬁrmed that UVA irradi-
ation alone generated ROS in a dose-dependent manner.
The presence of DNA S
4TdR did not, however, signiﬁ-
cantly (P>0.05) increase the levels of ROS produced by
UVA indicating that it is not acting principally as a Type
II UVA photosensitizer.
DNA damage
Single-strand breaks, oxidized DNA guanine and
cyclobutane pyrimidine dimers. The alkaline comet assay
(30) was used to determine whether DNA S
4TdR
photoactivation leads to DNA strand breakage or oxida-
tive DNA damage. A modest dose of UVA, 50kJ/m
2,
caused just detectable DNA single-strand breakage in
HaCaT cells. The presence of DNA S
4TdR did not detect-
ably inﬂuence strand breakage at this UVA dose, whereas
a UVA dose of 200kJ/m
2 caused a substantial increase
(Figure 3B).
The alkaline comet assay combined with recombinant
human OGG-1 DNA glycosylase (hOGG-1) treatment as
a probe for oxidative DNA damage indicated that UVA
doses of 50 and 200kJ/m
2 generated measurable DNA
8-oxoguanine in HaCaT cells. The presence of S
4TdR
did not alter the hOGG-1 sensitivity of DNA following
irradiation with 50kJ/m
2 UVA (Figure 3B). Thus, in
agreement with the inability of DNA S
4TdR to serve as
a source of UVA-generated ROS, it does not detectably
increase UVA-induced DNA guanine oxidation.
In parallel assays, inclusion of the cyclobutane pyrimi-
dine dimer (CPD)-speciﬁc T4 endonuclease V (T4N5) (31)
introduced signiﬁcant DNA breakage in cells treated with
50kJ/m
2 or 200kJ/m
2 UVA. S
4TdR treatment did not
increase T4N5 susceptibility of DNA from cells exposed
to 50kJ/m
2 UVA (Figure 3B). These data conﬁrm the
introduction of CPD by UVA (32) and indicate further
that DNA substitution by S
4TdR does not measurably
increase their formation.
In summary, UVA radiation induces DNA single-
strand breaks, oxidized guanine and CPD in HaCaT
cells. Despite acting as a UVA sensitizer for killing by
UVA, DNA S
4TdR does not detectably increase the
yield of any of these DNA photoproducts even under con-
ditions that are supralethal and result in <1% cell
survival (Supplementary Figure S1B). These ﬁndings are
consistent with the inability of DNA S
4TdR to increase
the yield of UVA-induced ROS in these cells and suggest
that alternative DNA lesions underlie its cytotoxic
potential.
Double-strand breaks. The accumulation of foci of phos-
phorylated histone H2AX (gH2AX) is a hallmark of the
cellular response to DSB (33). HaCaT cells that had been
treated with S
4TdR (100mM, 48h) were UVA irradiated
and gH2AX was detected by immunocytochemistry. After
4h of irradiation, most S
4TdR-treated cells displayed
a pan-nuclear staining (Figure 4) that is consistent with
inhibited replication. In contrast, following gamma ir-
radiation (10Gy) discrete focal gH2AX staining which
reﬂects the presence of DSB was observed in all cells.
Neither UVA nor S
4TdR alone induced gH2AX
staining. These ﬁndings suggest that shortly after UVA
irradiation, Double-strand breaks (DSBs) are generated
in, at most, a small minority of S
4TdR-treated cells.
They are also consistent with previous observations that
no Enzyme
+T4N5
+hOGG-1
S4TdR [μM]
UVA [kJ/m2]0 05 0 5 0 200
0
80
40
0
100 0 100 0
D
N
A
 
i
n
 
t
a
i
l
 
[
%
]
B
A
c
e
n
c
e
 
y 4000
6000
M
e
a
n
 
F
l
u
o
r
e
s
c
I
n
t
e
n
s
i
t
250
500
2000
0 0
S4TdR
UVA [kJ/m2]
- +
- -
--- ++
11 0 5 011 0 5 0
+
Figure 3. (A) Reactive oxygen species. HaCaT cells were grown for
48h in medium containing 100mMS
4TdR to replace  0.1% of DNA
thymidine. PBS-washed cells were incubated with the ROS-sensitive
probe CM-H2DCFDA, irradiated with UVA as indicated and
ROS-induced ﬂuorescence measured by ﬂow cytometry. Data are pre-
sented as the mean ﬂuorescence intensity±standard deviation of three
experiments. (B) DNA single-strand breaks/guanine oxidation/
cyclobutane pyrimidine dimer (CPD) formation. HaCaT cells grown
in the presence or absence of 100mMS
4TdR were washed and
irradiated with 50 or 200kJ/m
2 UVA as indicated. Direct DNA
single-strand breakage was analysed by the alkaline comet assay (No
enzyme, black bars). The presence of DNA 8-oxoguanine was revealed
by digestion with hOGG-1 (+hOGG-1, open bars) and CPDs by diges-
tion with T4N5 (+T4N5, grey bars) as indicated. DNA damage is ex-
pressed as percentage of DNA in the comet tail.
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4TdR photoactivation induces a severe inhib-
ition of DNA replication (Montaner, B. and Karran, P.,
unpublished data).
S
4TdR photoproducts
S
4TdR in dilute solution. We examined the stability of the
free thiodeoxynucleoside to UVA irradiation. An aqueous
S
4TdR solution (0.1mM) was irradiated and the products
were separated by reverse phase HPLC. UVA induced a
dose-dependent disappearance of S
4TdR (Figure 5) with
the concurrent appearance of three photoproducts. Mass
spectrometry identiﬁed thymidine as the predominant
species. The remaining photoproducts comprised small
amounts of dimeric S
4TdR (T
sT) and thymidine sulp-
henate (T
SO) in approximately equal yields. The nature
of dimeric photoproduct is not yet completely deﬁned.
Its UV absorbance spectrum has a maximum at 306nm
which is close to that of S
4-methylthymidine ( max 314nm)
and S
4-hydroxyethylthiothymidine ( max 308nm). For this
reason, we tentatively assign a T
ST rather than disulphide-
linked (T
SST) structure. The identiﬁcation of thymidine
sulphenate was based upon high resolution MS analysis
(275.06) of the isolated peak and its unusual UV absorp-
tion ( max 357nm).
Thus, in aqueous solution, the most favoured reaction
of photoactivated S
4TdR is with water to generate thymi-
dine. Since S
4T base pairs with A, this reaction generates a
canonical base pair in DNA. For this reason, it will not
contribute signiﬁcantly to the cytotoxicity of S
4TdR/
UVA. These ﬁndings suggest that reactions with the sur-
rounding DNA bases or DNA-interacting proteins might
be important in the formation of potentially lethal DNA
photolesions in treated cells.
S
4TdR in oligonucleotides. A series of synthetic oligo-
nucleotides that contained a single S
4TdR (Table 1) were
used to examine the effects of UVA irradiation on DNA
S
4TdR in different sequence contexts. Oligonucleotides
were irradiated in either single- or double-stranded form
and digested to nucleosides which were separated by
RP-HPLC. Column eluates were monitored at 335nm
(S
4TdR), 260nm (normal nucleosides) and by ﬂuorescence
(Ex 320nm; Em 370nm).
Figure 6A and B shows representative HPLC proﬁles
for the digests of the duplex oligonucleotide in which the
TS
4TG oligonucleotide is annealed to a complementary
Untreated S4TdR UVA S4TdR+UVA
γ γH2AX
DAPI
Ionizing
Radiation
Figure 4. g-H2AX staining. HaCaT cells grown in the presence of 100mMS
4TdR for 48h were irradiated with 10kJ/m
2 UVA as shown. Control
cells grown in the absence of S
4TdR were treated with 10Gy of gamma irradiation. In each case, g-H2AX was visualized 4h later. Note the
pan-nuclear g-H2AX staining induced by S
4TdR/UVA treatment which differs from the discrete focal staining following gamma irradiation. DNA
was counterstained with 40,6-diamidino-2-phenylindole (DAPI).
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Figure 5. UVA photostability of S
4TdR in dilute solution. A 0.1mM
aqueous solution of S
4TdR was irradiated with UVA as shown.
Samples were analysed by HPLC. Products were detected by A260 or
A335 and quantiﬁed. Further conﬁrmation of T
SO and T
ST was
obtained by mass spectrometry analysis.
Table 1. Sequences of the S
4T-containing synthetic oligonucleotides
used to examine the effects of UVA irradiation on DNA S
4TdR in
different sequence contexts
Sequence Code
50-GAATCAGCCS
4TGCACAGATACGAG-30 CS
4TG
GAATCAGCTS
4TGCACAGATACGAG TS
4TG
GAATCAGCGS
4TTCACAGATACGAG GS
4TT
GAATCAGCGS
4TCCACAGATACGAG GS
4TC
GAATCAGCGS
4TGCACAGATACGAG GS
4TG
GAATCAGCGS
4TACACAGATACGAG GS
4TA
S
4T= 4-thiothymine.
Abbreviations used in the text for the sequences are given in the Code
column.
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4T:A pair ﬂanked by a 50T and a
30G (Table 1). A UVA dose of 10kJ/m
2 reduced the yield
of S
4TdR (elution time 26min) by >60% and this coin-
cided with the appearance of a ﬂuorescent product eluting
at 19min (Figure 6B). This photoproduct also absorbed
at 315nm. The destruction of S
4TdR and the formation
of the ﬂuorescent/A315 absorbing material were lin-
early related to UVA dose  10kJ/m
2 (Figure 6C–E).
UVA irradiation of the single-stranded TS
4TG oligo-
nucleotide generated the same 19-min product in a simi-
larly dose-dependent fashion in approximately similar
yields (data not shown).
S
4T was more UVA resistant in the closely related
GS
4TT duplex in which it is paired to A and ﬂanked by
50G:C and a 30T:A pairs (Table 1). A dose of 10kJ/m
2
destroyed only  10% of the S
4TdR (Figure 7A). Higher
UVA doses were more effective and only 30% of the
starting S
4TdR remained after 100kJ/m
2. No photoprod-
ucts were detectable by ﬂuorescence (Figure 7B), A335 or
A260 (data not shown). In particular, there was no con-
comitant increase in recovery of TdR, conﬁrming that the
photochemistry of DNA S
4TdR differs from that of the
free thionucleoside. The photosensitivity of S
4TdR in
single- or double-stranded GS
4TT was typical of oligo-
nucleotides in which S
4T was not immediately 30 to
T. These included CS
4TG indicating that a 50C cannot
substitute for T to confer enhanced UVA sensitivity.
Comparison between TS
4TG and other duplex oligo-
nucleotides (CS
4TG&G S
4TT) is presented in Figure 7C.
Based on these ﬁndings, we conclude that S
4TdR in
single- or double-stranded DNA is susceptible to destruc-
tion by UVA. It is atypically photosensitive when placed
30- but not 50T. In the former context, we observed a
photoproduct with ﬂuorescence and absorbance proper-
ties consistent with those reported for thio (6-4)T:T,
(S
5-(6-4)T:T) (16), which is analogous to the (6-4) Py:Py
UVC/UVB DNA photoproduct. The likely identity of the
S
5-(6-4)T:T was conﬁrmed by ELISA assays. Figure 7D
shows that the UVA-irradiated TS
4TG oligonucleotide
was recognized by the antibody against (6-4) Py:Py and
gave a strong ELISA signal. In contrast, irradiated
GS
4TT gave only background signals. In the absence of
Figure 6. UVA photoproducts in oligonucleotides containing S
4TdR with a 50T. The oligonucleotide TS
4TG annealed to a complementary strand to
place a single S
4T:A base pair 30 to T:A base pair was irradiated with 10kJ/m
2 UVA. Following digestion to nucleosides, the products were analysed
by RP-HPLC and the eluate monitored by: (A)A 335. Upper trace unirradiated. Lower trace 10kJ/m
2 UVA. The absorbance scale is the same for
both traces. The arrow indicates S
4TdR eluting at 26min. (B) Fluorescence (Ex 320nm; Em 370nm). Upper trace unirradiated. Lower RP-HPLC
trace 10kJ/m
2 UVA. The arrow indicates the ﬂuorescent photoproduct eluting at 19min. Fluorescence scale is the same for both traces. (C) UVA
dose dependence of S
4TdR destruction. Residual S
4TdR in digests of irradiated TS
4TG duplexes was quantiﬁed from A335 nm absorbance following HPLC
separation. (D) UVA dose dependence of the formation of the ﬂuorescent (D) and 315nm absorbing (E) photoproduct eluting from HPLC at 19min.
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4TdR requires higher UVA
doses and is not associated with photoproducts with
detectable UVA or UVC absorbance or ﬂuorescence
under our standard conditions. Although TdR is the pre-
dominant UVA photoproduct after high-dose irradiation
of S
4TdR in aqueous solution, we did not see an equiva-
lent efﬁcient conversion to TdR in irradiated
oligonucleotides.
DNA interstrand crosslinks
When duplex S
4TdR oligonucleotides were UVA irradi-
ated and analysed by denaturing PAGE, a radioactive
photoproduct that migrated with the characteristics of a
cross-linked duplex was observed. Interstrand crosslinks
(ICL) formation was UVA dose-dependent. The
efﬁciencies of crosslinking with the GS
4TA, GS
4TT and
TS
4TG duplexes were not widely different, suggesting that
the generation of ICL is largely independent of the imme-
diate sequence context of the S
4TdR (Figure 8).
Crosslinking was dependent on the presence of the com-
plementary strand and UVA irradiation did not induce a
change in migration of single-stranded S
4TdR-containing
oligonucleotides (Figure 8, middle panel).
DNA repair
In order to investigate the potential toxicity of S
4TdR
DNA photoproducts, we examined the S
4TdR/UVA sen-
sitivity of a number of cell lines with known DNA repair
defects. The previously reported hypersensitivity of
NER-defective XPA cells was conﬁrmed (Supplementary
Figure S2).
DNA DSB rejoining. DNA S
4TdR photoproducts inhibit
replication (Montaner, B. and Karran, P., unpublished
data). Homologous recombinational repair (HR) is one
of the predominant pathways by which lesions that
impair replication are processed. At comparable levels of
DNA S
4TdR ( 0.3% replacement of TdR), HR-defective
xrcc2 hamster cells were extremely sensitive to UVA.
Whereas >80% of xrcc2
+ cells survived a UVA dose of
0.1kJ/m
2, the same dose reduced survival of the HR-
defective cells to around 1% (Figure 9A). In the absence
of S
4TdR pre-treatment, neither the HR-proﬁcient nor
HR-defective cells were affected by these very low UVA
doses. To address DSBs that arise outside of S phase, we
examined cells defective in the non-homologous end
joining (NHEJ) pathway. Neither the NHEJ-defective
Figure 7. UVA photoproducts in oligonucleotides containing S
4TdR with a 50Go rC( A and B) The GS
4TT duplex was irradiated with 10kJ/m
2
UVA and analysed as described in the legend to Figure 6A and B. Eluted S
4TdR (26min) is shown as arrows. The A335 scales in the two panels in A
and the ﬂuorescence (Ex 320; Em 370) scales in B are the same for both traces. (C) UVA dose-dependence of S
4TdR destruction in the CS
4TG and
GS
4TT duplexes. Residual S
4TdR in digests of irradiated duplexes was quantiﬁed from A335. Data for the TS
4TG duplex are shown for comparison.
(D) Detection by ELISA of photoproducts in UVA (10kJ/m
2) irradiated TS
4TG and GS
4TT duplexes. Inset: ELISA of DNA extracted from
CCRF-CEM cells irradiated with 10J/m
2 UVC.
Nucleic Acids Research, 2011,Vol.39, No. 22 9627(Ku80 mutant) xrs6, nor the repair-proﬁcient parental K1
hamster cells exhibited any S
4TdR-related sensitivity over
the UVA dose range that was extremely toxic to the
HR-defective cells (data not shown). The xrs6 cells
incorporated S
4TdR poorly, however, and in several ex-
periments replaced  0.03% of DNA TdR compared with
the 0.3% for the parental CHO K1 cells. Owing to this,
we are unable to draw ﬁrm conclusions about the contri-
bution of NHEJ to S
4TdR/UVA resistance. Taken
together with the ﬁndings from the gH2AX immunocyto-
chemistry, however, the data indicate that DNA lesion(s)
that block replication and thereby generate DSB that
require HR for repair are a major contributor to the
lethal effects of S
4TdR/UVA.
DNA crosslink processing. The HR pathway is part of the
complex system that processes ICL. The XPF:ERCC1
endonuclease is also involved and XPF-deﬁcient cells are
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Figure 9. S
4TdR/UVA sensitivity in DNA repair-defective cell lines. (A) Homologous recombination. xrcc2-deﬁcient CHO irs1 cells and their
XRCC2 complemented counterparts were grown for 48h in 100mMS
4TdR and UVA irradiated at the doses indicated. Survival was determined
by clonal assay. (B) XPF and XPG. CHO UV135 (XPG) and CHO UV41 (XPF) cells were treated as in A. Survival was determined by clonal assay.
(C) Fanconi A. FancA-defective and FancA-corrected MEFs were treated as in A. Survival was determined by clonal assay.
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AAC
Figure 8. DNA interstrand photocrosslinking in S
4TdR-containing duplex oligonucleotides. The GS
4TA, GS
4TT and TS
4TG oligonucleotides were
annealed to their [
32P]-labelled complementary strands and irradiated with the UVA doses shown. A [
32P]-labelled unannealed GS
4TT strand was
also irradiated with 50kJ/m
2 UVA (far left lane of central panel). Products were separated by denaturing PAGE and detected by autoradiography.
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agents. CHO UV41 cells are defective in the hamster
homolog of XPF. Figure 9B shows that 0.1kJ/m
2 UVA
reduced the survival of S
4TdR-treated UV41 cells to
 0.1%. At comparable levels of DNA S
4TdR (0.2–
0.3%), the parental AA8 cells were essentially insensitive
to UVA at doses up to ﬁve times higher. The UV135 XPG
mutant CHO cells exhibited an intermediate sensitivity
compatible with their NER defect (Figure 9B). Mouse
embryonic ﬁbroblasts defective in the FancA protein, a
member of the Fanconi anaemia (FA) pathway core
complex, were also more sensitive to S
4TdR/UVA than
their FancA-proﬁcient counterparts (Figure 9C). The
pattern of S
4TdR/UVA sensitivity among these various
mutant cell lines indicates that ICL are a signiﬁcant con-
tributor to toxicity.
DNA S
5-(6-4)T:T and excision repair
We examined whether the S
5-(6-4)T:T lesion was detect-
able in DNA from S
4TdR/UVA-treated cells and whether
it was subject to excision repair. HaCaT cells in which
S
4TdR replaced between 0.1% and 0.2% of DNA TdR
were irradiated with UVA and DNA was extracted imme-
diately or  24h after irradiation. DNA digests were ana-
lysed by HPLC with ﬂuorescence detection. Figure 10A
shows that a photoproduct with the characteristic ﬂuores-
cence and elution time (19min) of the S
5-(6-4)T:T lesion
was formed in cellular DNA. At 20kJ/m
2 UVA, 30–40%
of the DNA S
4TdR was destroyed. The ﬂuorescent photo-
product was easily detectable at doses as low 5kJ/m
2 and
formation was linear with UVA dose up to 20kJ/m
2, the
highest dose examined (Supplementary Figure S3A). At
similar levels of DNA S
4TdR (0.2%), the UVA dose de-
pendency of DNA S
4TdR destruction and of S
5-(6-4)T:T
formation in human CCRF-CEM cells was comparable
with that of HaCaT cells (Supplementary Figure S3B).
HaCaT cells removed S
5-(6-4)T:T lesions. Figure 10B
shows that they were excised with a half-life of between
6h and 12h. By 24h, the ﬂuorescent product was barely
detectable in DNA from cells treated with 5kJ/m
2 or
10kJ/m
2 UVA. The removal of UVC-induced DNA
Figure 10. Induction and repair of the thietane/S
5-(6-4)T:T photoproduct in HaCaT cells. (A) Formation of S
5-(6-4)T:T. HaCaT cells that had been
grown for 48h in 300mMS
4TdR were irradiated with 10kJ/m
2 UVA. DNA extracted immediately after irradiation was digested to nucleosides that
were separated by HPLC with ﬂuorescence (Ex 320nm; Em 370nm) detection. The arrow indicates the elution time of the thietane/S
5-(6-4)T:T
photoproduct. The ﬂuorescence scale is the same for both traces. (B) Excision of the thietane/S
5-(6-4)T:T photoproduct. HaCaT cells were treated
with S
4TdR (300mM/48h) and irradiated with UVA: 5 (ﬁlled grey square), 10 (open triangle) or 20 (ﬁlled black circle) kJ/m
2. XPA cells treated with
100mM/48h were irradiated with 5kJ/m
2 (ﬁlled black triangle). DNA was extracted, digested to nucleosides and analysed by HPLC. The thietane/S
5-
(6-4)T:T photoproduct was detected by its ﬂuorescence at 370nm. Thietane/S
5-(6-4)T:T levels are expressed by dividing the total ﬂuorescent signal
(mV) by the number of pmoles of TdR determined by A260 in the same sample. Inset: Excision of UVC-induced (6-4) Py:Py photoproducts. At the
times indicated, DNA was extracted from HaCaT cells irradiated with 30J/m
2 UVC and analysed by ELISA assay. (C) The thietane/S
5-(6-4)T:T
photoproduct equilibrium (38,39). The thietane species with the closed four-membered ring predominates and comprises  75% of the total. For a
normal (6-4) Py:Py photoproduct, the corresponding ring-closed oxetane structure is unstable and essentially all of this product is in the ring-open
form.
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they were excised with a half-life of <1h (Figure 10B,
insert). S
5-(6-4)T:T repair was signiﬁcantly less efﬁcient
in CCRF-CEM cells and they removed around half
of the initial photoproducts in 24h (Supplementary
Figure S3C). The S
5-(6-4)T:T lesions persisted at un-
changed levels for 24h in XPA-defective XP12RO cells
(Figure 10B) conﬁrming that repair of this photoproduct
is by NER.
The high sensitivity of the ﬂuorescence detection
renders S
5-(6-4)T:T photoproducts easily detectable in
HPLC eluates. These rare DNA adducts were not,
however, detectable in HaCaT cells by immunocytochem-
ical staining (Supplementary Figure S4) or by ELISA
(data not shown) using antibodies against UVC-induced
DNA (6-4) Py:Py lesions.
DISCUSSION
The powerful synergistic toxicity of S
4TdR and UVA in
cultured cells is well established (8,9). Its recently reported
effectiveness in inhibiting tumour growth in a rat bladder
carcinoma model (34) indicates that it is a promising
photochemotherapeutic option. The most attractive appli-
cation for S
4TdR would be for hyperproliferative skin
conditions that are readily accessible to UVA irradiation.
Possible limiting factors for effectiveness in this context
are penetration of UVA through the epidermis and accu-
mulation of DNA S
4TdR in the proliferating target cells.
As a ﬁrst step in establishing the possible efﬁcacy of
S
4TdR/UVA, we used reconstituted skin raft cultures, a
model which reproduces many of the three-dimensional
aspects of skin (20). In this model, modest radiation
doses delivered sufﬁcient UVA to the lower levels of the
epidermis to kill S
4TdR-sensitized cells. Recent evidence
from our laboratory shows that physiological doses of
UVA induce CPD in human skin (35). Importantly, in
our raft experiments, the penetrating UVA was not detect-
ably toxic without the photosensitizer. The rat bladder
carcinoma study provided indications that effective
levels of DNA S
4TdR can be achieved in the target cell
population. In that study, systemic (intravenous) treat-
ment resulted in signiﬁcantly higher levels of DNA
S
4TdR in dividing tumour cells than in the adjacent
normal bladder epithelium (34). It is also noteworthy
that incorporation into normal skin was extremely low,
suggesting that the treatment would selectively target
hyperproliferative epidermal cells while sparing normal
cells. Taken together, these studies indicate the potential
effectiveness of S
4TdR/UVA therapy. Treatment-induced
mutation and the possible development of therapy-related
cancer, is a potential hazard of any DNA damage-based
therapy. The study reported here demonstrates another
encouraging aspect of S
4TdR/UVA treatment, its rela-
tively weak mutagenicity. UVA photoactivation of DNA
S
4TdR combines effective cell killing with minimal poten-
tial long-term risks.
The weak mutagenicity of S
4TdR/UVA is at least par-
tially accounted for by its photosensitizing mechanism.
UVA activation of DNA S
4TdR does not generate
measurable ROS. As a consequence, the DNA damage it
produces appears to be qualitatively different to that
caused by high-dose UVA alone (36). Activation of
DNA S
4TdR did not detectably increase DNA
single-strand breakage or guanine oxidation and in this
regard, it differs from the effects of DNA 6-TG (24,25).
We cannot, however, entirely exclude the possible forma-
tion of these DNA lesions by S
4TdR/UVA, because the
simultaneous introduction of ICL reduces the sensitivity
of the comet assay. In this regard, we note that 6-TG/
UVA, which also causes interstrand DNA crosslinking,
induces single-strand breaks that are easily measurable
by the comet assay (24). It is clear that, in comparison
with 6-TG/UVA treatment, single-strand breakage and
DNA guanine oxidation are relatively infrequent events
in cells treated with S
4TdR/UVA.
The extreme sensitivity of NER-deﬁcient cells and cells
with defects in HR or in the processing of ICL indicates
that the cytotoxicity of S
4TdR/UVA depends on its ability
to induce bulky DNA lesions that are severe impediments
to DNA replication. We identiﬁed two possible candidate
DNA lesions: ICL and a S
5-(6-4)T:T adduct. ICL are
among the most difﬁcult DNA lesions for the cell to
process. They prevent the helix unwinding, which is an
essential step in DNA excision repair, replication
and transcription. Their processing involves a complex
interplay between some NER proteins, specialized DNA
polymerases, members of the Fanconi anaemia family
of proteins and those of HR (37). Defects in any of
these proteins confer extreme sensitivity to ICL. The sen-
sitivity proﬁles of the cells we examined, in particular the
hypersensitivity of the irs1 and UV41 cell lines, are con-
sistent with a signiﬁcant contribution of ICL to the cyto-
toxicity of S
4TdR/UVA. This conclusion is reinforced
by the ease of ICL formation in duplex oligonucleo-
tides in vitro. Crosslinking occurred at low doses of
UVA, was independent of the sequences surrounding the
S
4TdR and involved a canonical base in the comple-
mentary DNA strand. All of these observations suggest
that ICL are likely to be abundant in cells in which,
as many as, 10
7 DNA thymines may be replaced by
S
4TdR. In agreement with this possibility, comet assays
of S
4TdR/UVA-treated bladder carcinoma cells reveal
extensive DNA crosslinking that is only partially
reversed by protease digestion to remove DNA-adducted
proteins (34).
Our ﬁndings also conﬁrm the particular photosensitivity
of S
4T when it is immediately 30 to a normal thymine in
DNA. The ﬂuorescent product that was formed after ir-
radiation of the TS
4TG duplex has the properties reported
for the S
5-(6-4)T:T adduct which resembles the DNA (6-4)
Py:Py lesion (38,39). The S
5-(6-4)T:T adduct was also de-
tectable in DNA from S
4TdR/UVA treated cells. HaCaT
keratinocytes excised these photoproducts quite efﬁcient-
ly. Nevertheless, they were more persistent than
UVC-induced (6-4) Py:Py lesions. We observed a rapid
removal of (6-4) Py:Py lesions, consistent with their
reported half-life of  1h in HaCaT cells (40). Removal
of S
5-(6-4)T:T adducts was even slower in CCRF-CEM
leukaemia cells in which most of them persisted for up
to 24h.
9630 Nucleic Acids Research, 2011,Vol.39, No. 22Rapid repair of (6-4) Py:Py lesions reﬂects the signiﬁ-
cant DNA distortion they create. The relative persistence
of S
5-(6-4)T:T suggests that it may cause less DNA distor-
tion. This, in turn, may reﬂect the greater stability of the
ring-closed, thietane form (38,39). Despite obvious struc-
tural similarities between S
5-(6-4)T:T and (6-4) T:T—they
are identical except for the replacement of the single O
4
atom of the 30-thymine by S in the former—there are sig-
niﬁcant differences in behaviour (16,38,39). In particular,
although, both photoproducts are formed via a
four-membered closed ring intermediate, the ring-closed
oxetane isomer of the (6-4) T:T is unstable and is imme-
diately converted to the open ring form. The thietane is
more stable and exists as an equilibrium mixture in which
the ring-closed thietane is favoured over S
5-(6-4)T:T
(38,39) (Figure 10C). It is possible that, although the
structural similarities between (6-4) T:T and thietane
permits recognition of the latter in the (6-4) Py:Py
ELISA assay, the rotational constraints imposed by the
four-membered ring mitigate DNA distortion by the
thietane and impede its recognition by NER. We note,
however, that in order to induce detectable levels of
thietane/S
5-(6-4)T:T photoproducts, it was necessary to
expose cells to combinations of S
4TdR and UVA that
cause signiﬁcant cell death. It is therefore, possible that
the one or more of the other DNA S
4TdR photoproducts,
such as ICL, interferes with the processing of thietane/S
5-
(6-4)T:T lesions by NER. These possibilities are currently
under investigation.
This study conﬁrmed the extreme sensitivity of
XP12RO cells. These ﬁndings indicate that NER repairs
potentially lethal S
4TdR/UVA DNA damage. The
sequence dependency of DNA thietane/S
5-(6-4)T:T for-
mation suggests that these lesions may comprise a relative-
ly minor fraction of the total DNA photoproducts.
Despite this, they contribute signiﬁcantly to the lethal
effects of S
4TdR/UVA. The NER system is particularly
efﬁcient in keratinocytes (41,42) and the superior repair of
thietane/S
5-(6-4)T:T lesions by HaCaT cells is associated
with a high survival. XP129, a UVC-resistant ‘revertant’
of XP12RO, which has regained a normal ability to excise
(6-4) Py:Py, but not other UVC photoproducts (43,44)
provides additional evidence linking thietane/S
5-(6-4)T:T
to toxicity. XP129 cells are only slightly ( 2-fold) more
sensitive to S
4TdR/UVA than NER proﬁcient cells (45).
This contrasts to the  100-fold sensitivity of the parental
XP12RO cells and emphasizes the likely cytotoxicity of
unrepaired thietane/S
5-(6-4)T:T lesions.
In summary, UVA photoactivation of S
4TdR—a highly
efﬁcient cytotoxic combination in cultured cells—has
properties that suggest it might be an effective highly
targeted treatment for hyperproliferative skin conditions.
Sufﬁcient UVA penetrates reconstituted skin and skin
in vivo to generate cytotoxic DNA lesions in the lower
levels of the epidermis. Its low mutagenicity suggests
that the combination is a potentially effective and safe
therapeutic option. The DNA lesions generated by these
photosensitized reactions differ from those produced by
high-dose UVA alone and thietane/S
5-(6-4)T:T photo-
products and ICLs are both likely contributors to the
cytotoxicity of S
4TdR/UVA.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures S1–S4.
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